Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
FitLife Brands ( (FTLF) ) has shared an announcement.
On August 8, 2025, FitLife Brands successfully closed the acquisition of substantially all assets of Irwin Naturals and its affiliates for $42.5 million, following approval by the U.S. Bankruptcy Court for the Central District of California. The acquisition, funded through a combination of a new term loan, a revolving line of credit, and FitLife’s cash reserves, is expected to drive revenue and earnings growth, enhancing FitLife’s market position in the nutritional supplements industry.
The most recent analyst rating on (FTLF) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on FitLife Brands stock, see the FTLF Stock Forecast page.
Spark’s Take on FTLF Stock
According to Spark, TipRanks’ AI Analyst, FTLF is a Outperform.
FitLife Brands’ strong financial performance and strategic acquisition of Irwin Naturals are the most significant factors driving the stock score. While technical indicators show positive momentum, caution is advised due to potential overbought conditions. The valuation is reasonable, but earnings call insights highlight challenges that need addressing. Overall, the company’s growth prospects and strategic initiatives provide a positive outlook.
To see Spark’s full report on FTLF stock, click here.
More about FitLife Brands
FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. The company markets over 250 different products primarily online, as well as through domestic and international GNC franchise locations and various retail outlets. FitLife is headquartered in Omaha, Nebraska.
Average Trading Volume: 24,488
Technical Sentiment Signal: Buy
Current Market Cap: $136.4M
For detailed information about FTLF stock, go to TipRanks’ Stock Analysis page.